Slc26a1 is not essential for spermatogenesis and male fertility in mice

PeerJ. 2023 Dec 15:11:e16558. doi: 10.7717/peerj.16558. eCollection 2023.

Abstract

Thousands of genes are expressed in the testis of mice. However, the details about their roles during spermatogenesis have not been well-clarified for most genes. The purpose of this study was to examine the effect of Slc26a1 deficiency on mouse spermatogenesis and male fertility. Slc26a1-knockout (KO) mice were generated using CRISPR/Cas9 technology on C57BL/6J background. We found no obvious differences between Slc26a1-KO and Slc26a1-WT mice in fertility tests, testicular weight, sperm concentrations, or morphology. Histological analysis found that Slc26a1-KO mouse testes had normal germ cell types and mature sperm. These findings indicated that Slc26a1 was dispensable for male fertility in mice. Our results may save time and resources by allowing other researchers to focus on genes that are more meaningful for fertility studies. We also found that mRNAs of two Slc26a family members (Slc26a5 and Slc26a11) were expressed on higher mean levels in Slc26a1-KO total mouse testes, compared to Slc26a1-WT mice. This effect was not found in mouse GC-1 and GC-2 germ cell lines with the Slc26a1 gene transiently knocked down. This result may indicate that a gene compensation phenomenon was present in the testes of Slc26a1-KO mice.

Keywords: Fertility; Gene compensation; Slc26a1; Spermatogenesis; Testis.

MeSH terms

  • Animals
  • Antiporters* / genetics
  • Fertility* / genetics
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Semen*
  • Spermatogenesis / genetics
  • Sulfate Transporters* / genetics
  • Testis / metabolism

Substances

  • Slc26a1 protein, mouse
  • Sulfate Transporters
  • Antiporters

Associated data

  • figshare/10.6084/m9.figshare.23635794.v1

Grants and funding

This work was supported by the National Key Research and Development Program of China (2022YFC2702702), the University Synergy Innovation Program of Anhui Province (GXXT-2021-071), the Suzhou Science and Technology Development Plan (SZM2021010) and the Introduce Project of Clinical Medicine Experts of Suzhou Industrial Park (SZYQTD202104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.